Viewing Protocol Section

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT06494475
Ignite Creation Date: 2024-07-17 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06494475
Protocol Section: NCT06494475
Start Identification Module Data
Expand Identification Module Data
Brief Title: GBS-NNNN2 50 µg of Each Fusion Protein GBS-NN and GBS-NN2 in Combination With 500 µg Aluminum as Alhydrogel Given With and Without the Tdap Vaccine in Healthy Non-pregnant Women 18 to 49 Years of Age
Official Title: A Randomised Observer-Blind Trial to Evaluate the Immunogenicity Safety and Reactogenicity of a Group B Streptococcus Vaccine GBS-NNNN2 When 1 Dose is Administered Concomitantly With the Tdap Vaccine in Healthy-non Pregnant Women 18 to 49 Years of Age Compared to When Each Vaccine is Administered Alone
Acronym: None
Organization: Minervax ApS
Organization Class: OTHER
Organization Study ID: MVX009
Secondary IDs
Secondary ID Type Domain Link
2023-508563-73-00 CTIS None None
U1111-1300-2150 OTHER None None
Start Status Module Data
Status Verified Date: 2024-07
Overall Status: NOT_YET_RECRUITING
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Minervax ApS
Lead Sponsor Class: OTHER
Lead Sponsor: Minervax ApS
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload